173 related articles for article (PubMed ID: 25678113)
1. Localized delivery of mechano-growth factor E-domain peptide via polymeric microstructures improves cardiac function following myocardial infarction.
Peña JR; Pinney JR; Ayala P; Desai TA; Goldspink PH
Biomaterials; 2015 Apr; 46():26-34. PubMed ID: 25678113
[TBL] [Abstract][Full Text] [Related]
2. The E-domain region of mechano-growth factor inhibits cellular apoptosis and preserves cardiac function during myocardial infarction.
Mavrommatis E; Shioura KM; Los T; Goldspink PH
Mol Cell Biochem; 2013 Sep; 381(1-2):69-83. PubMed ID: 23712705
[TBL] [Abstract][Full Text] [Related]
3. Administration of a Synthetic Peptide Derived from the E-domain Region of Mechano-Growth Factor Delays Decompensation Following Myocardial Infarction.
Shioura K; Pena J; Goldspink P
Int J Cardiovasc Res; 2014 Jun; 3(3):1000169. PubMed ID: 25606570
[TBL] [Abstract][Full Text] [Related]
4. Sustained delivery of MGF peptide from microrods attracts stem cells and reduces apoptosis of myocytes.
Doroudian G; Pinney J; Ayala P; Los T; Desai TA; Russell B
Biomed Microdevices; 2014 Oct; 16(5):705-15. PubMed ID: 24908137
[TBL] [Abstract][Full Text] [Related]
5. Mechano-growth factor reduces loss of cardiac function in acute myocardial infarction.
Carpenter V; Matthews K; Devlin G; Stuart S; Jensen J; Conaglen J; Jeanplong F; Goldspink P; Yang SY; Goldspink G; Bass J; McMahon C
Heart Lung Circ; 2008 Feb; 17(1):33-9. PubMed ID: 17581790
[TBL] [Abstract][Full Text] [Related]
6. Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.
Cittadini A; Monti MG; Petrillo V; Esposito G; Imparato G; Luciani A; Urciuolo F; Bobbio E; Natale CF; Saccà L; Netti PA
Eur J Heart Fail; 2011 Dec; 13(12):1264-74. PubMed ID: 22045926
[TBL] [Abstract][Full Text] [Related]
7. Mechano Growth Factor E peptide (MGF-E), derived from an isoform of IGF-1, activates human muscle progenitor cells and induces an increase in their fusion potential at different ages.
Kandalla PK; Goldspink G; Butler-Browne G; Mouly V
Mech Ageing Dev; 2011 Apr; 132(4):154-62. PubMed ID: 21354439
[TBL] [Abstract][Full Text] [Related]
8. Metabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodelling.
Robinson E; Tate M; Lockhart S; McPeake C; O'Neill KM; Edgar KS; Calderwood D; Green BD; McDermott BJ; Grieve DJ
Cardiovasc Diabetol; 2016 Apr; 15():65. PubMed ID: 27079193
[TBL] [Abstract][Full Text] [Related]
9. A collagen hydrogel loaded with HDAC7-derived peptide promotes the regeneration of infarcted myocardium with functional improvement in a rodent model.
Zhang Y; Zhu D; Wei Y; Wu Y; Cui W; Liuqin L; Fan G; Yang Q; Wang Z; Xu Z; Kong D; Zeng L; Zhao Q
Acta Biomater; 2019 Mar; 86():223-234. PubMed ID: 30660010
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
Ambrose J; Pribnow DG; Giraud GD; Perkins KD; Muldoon L; Greenberg BH
J Cardiovasc Pharmacol; 1999 Mar; 33(3):433-9. PubMed ID: 10069680
[TBL] [Abstract][Full Text] [Related]
11. Effect of testosterone on post-myocardial infarction remodeling and function.
Nahrendorf M; Frantz S; Hu K; von zur Mühlen C; Tomaszewski M; Scheuermann H; Kaiser R; Jazbutyte V; Beer S; Bauer W; Neubauer S; Ertl G; Allolio B; Callies F
Cardiovasc Res; 2003 Feb; 57(2):370-8. PubMed ID: 12566109
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone improves cardiac function in rats with experimental myocardial infarction.
Isgaard J; Kujacic V; Jennische E; Holmäng A; Sun XY; Hedner T; Hjalmarson A; Bengtsson BA
Eur J Clin Invest; 1997 Jun; 27(6):517-25. PubMed ID: 9229233
[TBL] [Abstract][Full Text] [Related]
13. Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction.
Sonnenberg SB; Rane AA; Liu CJ; Rao N; Agmon G; Suarez S; Wang R; Munoz A; Bajaj V; Zhang S; Braden R; Schup-Magoffin PJ; Kwan OL; DeMaria AN; Cochran JR; Christman KL
Biomaterials; 2015 Mar; 45():56-63. PubMed ID: 25662495
[TBL] [Abstract][Full Text] [Related]
14. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
[TBL] [Abstract][Full Text] [Related]
15. IGF-1 expression in infarcted myocardium and MGF E peptide actions in rat cardiomyocytes in vitro.
Stavropoulou A; Halapas A; Sourla A; Philippou A; Papageorgiou E; Papalois A; Koutsilieris M
Mol Med; 2009; 15(5-6):127-35. PubMed ID: 19295919
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat.
Duerr RL; McKirnan MD; Gim RD; Clark RG; Chien KR; Ross J
Circulation; 1996 Jun; 93(12):2188-96. PubMed ID: 8925588
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte and Vascular Smooth Muscle-Independent 11β-Hydroxysteroid Dehydrogenase 1 Amplifies Infarct Expansion, Hypertrophy, and the Development of Heart Failure After Myocardial Infarction in Male Mice.
White CI; Jansen MA; McGregor K; Mylonas KJ; Richardson RV; Thomson A; Moran CM; Seckl JR; Walker BR; Chapman KE; Gray GA
Endocrinology; 2016 Jan; 157(1):346-57. PubMed ID: 26465199
[TBL] [Abstract][Full Text] [Related]
18. Exogenous insulin-like growth factor II enhances post-infarction regional myocardial function in swine.
Battler A; Hasdai D; Goldberg I; Ohad D; Di Segni E; Bor A; Varda-Bloom N; Vered Z; Kornowski R; Lake M
Eur Heart J; 1995 Dec; 16(12):1851-9. PubMed ID: 8682018
[TBL] [Abstract][Full Text] [Related]
19. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.
Jayasankar V; Bish LT; Pirolli TJ; Berry MF; Burdick J; Woo YJ
Ann Thorac Surg; 2004 Jun; 77(6):2122-9; discussion 2129. PubMed ID: 15172279
[TBL] [Abstract][Full Text] [Related]
20. Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats. Effects of chronic angiotensin converting enzyme inhibition.
Litwin SE; Litwin CM; Raya TE; Warner AL; Goldman S
Circulation; 1991 Mar; 83(3):1028-37. PubMed ID: 1999008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
